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Abstract
The majority of bovine spongiform encephalopathy (BSE) cases have been ascribed to the classical form of the disease. H-
type and L-type BSE cases have atypical molecular profiles compared to classical BSE and are thought to arise
spontaneously. However, one case of H-type BSE was associated with a heritable E211K mutation in the prion protein gene.
The purpose of this study was to describe transmission of this unique isolate of H-type BSE when inoculated into a calf of
the same genotype by the intracranial route. Electroretinograms were used to demonstrate preclinical deficits in retinal
function, and optical coherence tomography was used to demonstrate an antemortem decrease in retinal thickness. The
calf rapidly progressed to clinical disease (9.4 months) and was necropsied. Widespread distribution of abnormal prion
protein was demonstrated within neural tissues by western blot and immunohistochemistry. While this isolate is
categorized as BSE-H due to a higher molecular mass of the unglycosylated PrP
Sc isoform, a strong labeling of all 3 PrP
Sc
bands with monoclonal antibodies 6H4 and P4, and a second unglycosylated band at approximately 14 kDa when
developed with antibodies that bind in the C-terminal region, it is unique from other described cases of BSE-H because of an
additional band 23 kDa demonstrated on western blots of the cerebellum. This work demonstrates that this isolate is
transmissible, has a BSE-H phenotype when transmitted to cattle with the K211 polymorphism, and has molecular features
that distinguish it from other cases of BSE-H described in the literature.
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Introduction
Prion diseases or transmissible spongiform encephalopathies
(TSEs) are fatal neurodegenerative diseases that naturally affect
several species including human beings. These chronic diseases are
associated with the accumulation of a protease-resistant, disease-
associated isoform of the prion protein (PrP
Sc) in the central
nervous system and other tissues, depending on the species
affected. In humans, TSEs can be acquired through exposure to
infectious material, inherited as germline polymorphisms in the
prion gene (prnp), or occur spontaneously.
Bovine spongiform encephalopathy (BSE), a TSE of cattle, can
be subdivided into at least three groups: classical, H-type, and L-
type. The latter 2 designations are based on higher or lower
apparent molecular mass profiles of the unglycosylated PrP
Sc band
in a western blot [1,2,3] and are collectively referred to as atypical
BSE. The vast majority of BSE cases are the classical subtype that
was associated with the UK BSE epizootic. Classical BSE has
spread to several mammalian species including human beings
[4,5,6] causing major animal health and public health concerns.
Epidemiological studies suggest that classical BSE is spread
through contaminated feedstuffs, and early in the UK epizootic it
was suspected that the origin of the disease was scrapie [7,8],
a TSE known to exist in sheep for over 200 years. However,
experimental transmission of scrapie to cattle by a natural route
has failed to produce disease, and while transmission of scrapie to
cattle by the intracranial route produces a disease in cattle, it fails
to accurately reproduce the clinical and pathologic features of BSE
in cattle [9,10]. Thus the origin of classical BSE remains unclear.
H-type BSE has been described in cattle from France [11],
Germany [1], Japan [12], the Netherlands [13], Poland [14],
Switzerland [15], the United Kingdom [16], Canada [17], and the
United States [18]. The molecular phenotype of the H-type BSE
cases is characterized by 1) a higher molecular mass of the
unglycosylated PrP
Sc isoform, 2) a strong labeling of all 3 PrP
Sc
polypeptides (unglycosylated, monoglycosylated and diglycosylated
isoforms) with the PrP-specific monoclonal antibodies 6H4 and P4,
and 3) a second unglycosylated band at approximately 14 kDa
when developed with antibodies that bind in the C-terminal region
(amino acids 154–236) such as SAF 84 [19].
Several hypotheses have been proposed to explain atypical BSE
cases [11]. At the forefront of this discussion is the possibility that
both H-type and L-type BSE may be spontaneous diseases in
cattle. Support for atypical BSE occurring spontaneously is drawn
from the parallels to sporadic TSE in humans, specifically,
occurrence in older hosts and a comparable low incidence rate.
Whereas numbers of cattle affected by classical BSE shows
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by atypical BSE remain relatively stable over time supporting the
hypothesis that these atypical cases occur spontaneously [20].
Furthermore, cases of atypical BSE are not influenced by prion
gene promoter region polymorphisms that influence susceptibility
to classical BSE [21], and atypical BSE occurs as isolated cases in
contrast to the clustering of cases observed for feedborne classical
BSE [22]. Recognition of a spontaneous TSE in cattle, coupled
with evidence indicating atypical BSE can convert to classical BSE
upon serial passage in mice [23,24,25], has broad implications for
our understanding of the origins of the classical form of the disease.
In 2006, a case of BSE was diagnosed in the U.S. that led to the
identification of a new prion protein (prnp) allele, K211 [26], that is
associated with H-type BSE and is heritable [27]. There was
limited historical information available for this case and only
brainstem tissue was available for analysis. The purpose of this
study was to describe the transmission of a unique isolate of H-type
BSE derived from the 2006 U.S. case associated with the E211K
prion protein polymorphism when inoculated into a calf of the
same genotype. Clinical signs, antemortem test results, histopa-
thology, and tissue distribution of PrP
Sc by western blot (WB) and
immunohistochemistry (IHC) are reported here.
Results and Discussion
Clinical Findings
A calf with the K211 allele was intracranially inoculated with H-
type BSE from the US 2006 BSE case that also had one K211
allele. This calf demonstrated clinical signs at approximately 9.4
months (288 days) post-inoculation (PI). Initial signs were non-
descript: listlessness, head down in non-physiologic position with
drooping ears, and decreased feed consumption. Within a week,
clinical signs had progressed to the calf separating himself from
others in the pen, head pressing into the wall or gate, and
intermittent reluctance to rise with a stumbling gate for a brief
time after rising. The calf began to demonstrate a lip licking and
accentuated chewing behavior that was not associated with
feeding. The lip-licking and chewing behaviors increased in
frequency and severity, and at the time of necropsy at
approximately 9.8 months PI (301 days), the calf was depressed,
salivating excessively, and reluctant to rise.
Progression to severe clinical signs of BSE occurred in this
animal after 9.8 months, a faster onset than the 12–18 months
described for other experimental cases of H-type BSE
[28,29,30,31]. Previous studies describe the onset of clinical signs
for BSE-H as early as 8 months PI [31], but more commonly at 12
months PI [30] or later [28] with a 2–7 month progression of
disease to ataxia and inability to rise [28,30,31]. Our findings are
similar to other reports in that the earliest clinical signs appear to
be vague: weight loss, depression, and low head carriage.
However, reports of clinical findings in BSE-H are variable: from
ataxia and myoclonus that progresses to an inability to rise without
nervousness or aggression [30] to a nervous disease form that is
characterized by overeactivity to external stimuli, apprehension
and anxiety [31]. This case of E211K BSE-H is different in that
the most obvious outward clinical signs were bizarre licking and
chewing behaviors not described elsewhere. While the calf affected
with E211K was reluctant to rise, it was able to rise when
encouraged, however, this animal was younger and smaller than
cattle in other studies that had difficulty getting to their feet, which
may play a role in the difference reported.
Electroretinography
As the retina has proven to offer diagnostic promise in TSEs
[32,33], two non-invasive tools were utilized to assess retinal
changes during the incubation period. Retinal function and
thickness were assessed through electroretinography and optical
coherence tomography (OCT), respectively. Flash electroretinog-
raphy was performed prior to inoculation (0 months post-
inoculation; MPI)) and at 6 and 9 MPI. Data at the 9 MPI
time-point was collected approximately 1 week prior to the onset
of unequivocal neurologic signs. B-wave amplitude and implicit
time were measured for 2 scotopic (dark-adapted) tests (tests 1,2)
and 1 photopic (ambient light) test (test 3) (Fig. 1). B-wave
amplitude increased for all tests from 0 to 6 MPI, but did not
appreciably change from 6 to 9 MPI, which included the time of
onset of clinical signs (Table S1). However, the average b-wave
implicit time increased substantially over the course of disease. For
tests 1, 2, and 3 at 0 MPI, average b-wave implicit times were
65 msec (66), 27 msec (64), and 10.8 msec (60.3), respectively.
By 9 MPI, implicit time for each test was substantially prolonged
with average values for tests 1, 2, and 3 at 86 msec (65), 65 msec
(62.0), and 31.8 msec (65), respectively (Fig. 1). These findings
are consistent with our previous report demonstrating that while b-
wave amplitude is not affected, b-wave implicit time is prolonged
in cattle with prion disease [33].
Optical Coherence Tomography and Retinal Pathology
Retinal thickness was measured using optical coherence
tomography (OCT) 1 day prior to inoculation (0 MPI), at
9 MPI and immediately prior to necropsy. At 0 MPI, the average
retinal thickness measurement was 371 mm( 627). At 9 MPI the
retinal thickness had decreased to an average of 273 mm( 64).
One month later, immediately prior to necropsy, average retinal
thickness was not appreciably different at 275 mm( 66) (Fig. 1B).
To ensure that decreased retinal thickness could be attributed to
disease and not to the normal retinal thinning that accompanies
growth of the globe, we compared the retinal thickness measure-
ments of the calf with an age-matched non-inoculated control calf
that also had the E211K polymorphism. The average retinal
thickness of this control animal was 310 mm( 66), suggesting that
an appreciable amount of the retinal thinning observed in the
inoculated calf was associated with the disease process. While this
is the first published report using OCT in cattle, the retinal
thinning observed is consistent with prior reports of morphologic
change associated with disease [32,33,34,35,36,37].
Immunohistochemical analysis of retina demonstrated evidence
of PrP
Sc accumulation and a retinal response to injury. PrP
Sc
immunoreactivity in the retina was intense within the plexiform
layers and in the retinal ganglion cells (Fig. 2A). In addition to
PrP
Sc, the left and right globes were also labeled for glial fibrillary
acidic protein (GFAP), a cytoskeletal protein that is upregulated in
activated Mu ¨ller glia. GFAP immunoreactivity was used to further
assess the retinal injury related to disease. Compared to a non-
inoculated bovine control, GFAP-immunoreactivity was increased
in the retina of this calf (Fig. 2B). These findings are consistent
with reports of scrapie in sheep [34] and TME in cattle [33].
Distribution and Characterization of Lesions in BSE-H
Vacuolar lesions typical of spongiform encephalopathy were
present throughout the brain of this calf. Spongiform change was
most severe in the piriform cortex and hippocampus, but present
at all levels of brain examined. The distribution of lesions suggests
sampling at various levels of the brain, including the obex, would
be fruitful for diagnosis. Vacuolation scores ranged from 1 to 3
(scale of 0 to 4), but the vast majority of regions were scored a 2 or
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predominantly affected gray matter with little to no involvement of
white matter. Vacuoles were primarily present in the neuropil, but
were also detected within the cytoplasm of neurons (Fig. 3). At all
levels of the spinal cord, there were few inconclusive vacuoles
present in the neuropil of the dorsal horns.
Results of microscopic examination for vacuolar change in-
dicate that additional tools may be required to differentiate E211K
BSE from classical BSE or other isolates of BSE-H that have been
described in the literature [30,31]. Similar to other reports,
vacuolar change was generally observed in all brain areas and
moderate to severe vacuolar change was detected in cerebral
cortex, cerebellum, basal ganglia, thalamus, and brainstem
[30,31]. However, there were contrasts in the areas with the
highest vacuolation scores. The highest levels of spongiform
change were evident in piriform cortex and hippocampus in this
case, whereas the highest levels were in thalamic nuclei and
midbrain of other reports [30]. Profiles developed using larger
numbers of animals suggest that BSE-H may be difficult to
distinguish from classical BSE based on spongiform change in the
obex, but may have increased numbers of vacuoles in rostral brain
areas [31]. E211K BSE-H had the lowest scores in pontine and
hypoglossal motor nuclei, which was similar to previous reports of
BSE-H [30]. In summary, it appears that vacuolar change is
variable amongst different isolates classified as BSE-H. Caution
should be used when considering the lesion profile of this single
animal as what role individual animal differences or the E211K
polymorphism play cannot be determined without further
experimentation.
Microscopic evaluation of the brain of the US 2006 H-type BSE
case was limited to the obex and complicated by freeze artifact,
precluding a definitive microscopic interpretation [18]. Therefore,
this is the first description of the microscopic lesions in the CNS of
a bovid affected with H-type BSE associated with the E211K
polymorphism. No amyloid plaques were present in the tissues
from the calf with E211K BSE-H, which is similar to one previous
study of BSE-H [31], but contrasts with another [30].
Immunohistochemical analysis for PrP
Sc demonstrated wide-
spread immunoreactivity throughout the brain, spinal cord, and
retina with lesser immunoreactivity in neurohypophysis and the
trigeminal ganglia (Fig. S2). Regardless of the brain region
examined, PrP
Sc immunoreactivity was readily apparent. Immu-
noreactivity was most intense in the brainstem and midbrain and
Figure 1. Results of antemortem ophthalmologic testing. (A)Comparison of mean ERG b-wave implicit time at 0, 6, and 9 months post-
inoculation (MPI). Implicit time was prolonged at 9 MPI compared to baseline (0 MPI) and 6 MPI values for all test conditions. Test 1, dark adapted
0.024 cd?s/m
2; test 2, dark adapted 2.45 cd?s/m
2; test 3, light adapted 2.45 cd?s/m
2.( B) Optical Coherence Tomography (OCT) was used to measure
full retinal thickness, (including all retinal layers) of Calf 83 prior to inoculation (0 MPI), nine-months post inoculation (9 MPI) and one day prior to
necropsy (approximately 9.8 MPI). There was an appreciable decrease in retinal thickness from 0 MPI to 9 MPI. Retinal thickness was also decreased
relative to an age-matched, genotype matched, non-inoculated control (Calf 78). Error bars are standard deviation based on 10 measurements.
Abbreviations: cd?s/m
2=candela seconds per meter squared; msec=milliseconds.
doi:10.1371/journal.pone.0038678.g001
Figure 2. Retinal pathology corroborates antemortem findings.
(A) PrP
Sc immunoreactivity demonstrates that abundant PrP
Sc (red)
accumulates in the retina. Original magnification 206.( B) GFAP
immunoreactivity (brown) in the Mu ¨ller glia (arrow) indicates a response
to retinal injury. Original magnification 206.
doi:10.1371/journal.pone.0038678.g002
Figure 3. Spongiform change was present at all levels of the
brain examined. (A, B) Vacuoles were numerous and evenly spread in
the piriform cortex. Original magnification 46and 106, respectively. (C,
D) The parasympathetic nucleus of the vagus nerve contained few but
definitive spongiform lesions. Vacuoles occur predominantly in the
neuropil rather than perikarya. Original magnification 26 and 406,
respectively.
doi:10.1371/journal.pone.0038678.g003
BSE-H Associated with E211K Polymorphism
PLoS ONE | www.plosone.org 3 June 2012 | Volume 7 | Issue 6 | e38678patterns of immunoreactivity were similar to those previously
described [1,18,26,30,31]with an intraglial distribution predomi-
nating. The predominant patterns in the cortex were intraglial and
stellate on a background of fine punctate and granular particulate
staining that was multifocally coalescing (Fig. 4A). Perineuronal
staining was also evident, but intraneuronal immunoreactivity was
rare. Immunoreactivity increased in intensity from frontal cortex
caudal to occipital cortex. In the white matter subjacent to the
cortex, there were rare coarse particulate foci of immunoreactivity
that were most often associated with glial cell margins (Fig. S3).
This is in contrast to previous studies where glial staining in the
white matter was a more prominent feature in BSE-H [31]. We
did not see PrP
Sc immunoreactive plaques in the gray or white
matter, but other reports indicate that this occurs as a prominent
[30] or lesser [31] feature. Immunoreactivity in hippocampus,
midbrain, and brainstem was markedly intense and frequently
formed coalescing aggregates (Fig. 4B). While intraneuronal
straining was rare in the cortex, it became the most obvious
pattern in the midbrain and brainstem nuclei (Fig. 4D) with
notable exception of the parasympathetic nucleus of the vagus
nerve. Intraneuronal staining also was readily apparent in spinal
cord (Fig. S2). Immunoreactivity was scant in the cerebellum
where small, multifocal clumps of granular and particulate staining
occurred in the molecular and granular layers. The cerebellar
white matter was devoid of immunoreactivity except for in
association with deep cerebellar nuclei (Fig. S4), which is in
contrast to other studies of BSE-H where the most prominent
staining of the cerebellum was in the white matter [31].
Considering the strong immunoreactivity in other regions of the
brain, the scant immunoreactivity in cerebellum was surprising.
This finding corroborates recent studies examining PrP
Sc immu-
noreactivity in the brainstem and cerebellum of cases of BSE-H
where the cerebellum and caudal brainstem contained less PrP
Sc
than more rostral regions of the brainstem [31,38]The immuno-
histochemical techniques used here failed to demonstrate PrP
Sc in
other tissues examined. This finding is consisent with other studies
of atypical BSE that suggest that no significant PrPSc depositions
occur in peripheral tissues [39]. Other findings of the lesions
described contrast those described for wild-type cattle with BSE-H
[30] in that no PrP
Sc plaques were noted and that there is less
immunoreactivity in the cerebellum in this case. Whether the
E211K polymorphism influences lesion character or distribution
when inoculated with other BSE isolates will require further study.
Molecular Characterization of E211K BSE
Western blot analysis of this E211K BSE-affected calf was
performed using monoclonal antibodies 6H4, P4, and SAF-84
alongside control tissues from cattle affected with classical BSE and
BSE-H. On western blots labeled with mAb 6H4, cerebrum,
thalamus, colliculus, and obex demonstrated the characteristic
three-band pattern of prion disease with similar intensity of
unglycosylated, monoglycosylated, and diglycosylated bands. Not
previously described for BSE-H was the presence of an additional
band at approximately 23 kDa in tissue from the cerebellum of
calf #83 (Fig. 5A), which is not present on western blots of brain
homogenates from the same regions of cattle inoculated with
classical BSE or BSE-H. This additional band is also present when
mAb P4 is used, but not when primary antibody is omitted (data
not shown). Upon deglycosylation, the 23 kDa band is not
observed giving the blot an appearance similar to other BSE-H
isolates. While mAb P4 does not label PrP
Sc from animals with
classical BSE, labeling with mAb P4 is a characteristic of BSE-H
(Fig. 5B). The use of mAb SAF-84 further demonstrates the BSE-
H properties of E211K BSE with the characteristic low molecular
weight band of BSE-H at approximately 14 kDa. The 14-kDa
band is similarly present in non-E211K BSE-H, but not in classical
BSE (Fig. 5C). E211K BSE-H presents all the features necessary
for classification as BSE-H, specifically a higher molecular weight
banding profile than classical BSE and labeling with mAb P4.
However, E211K BSE-H remains distinct from other described
BSE-H by both the E211K polymorphism and the presence of an
additional (4
th) band at approximately 23 kDa in samples from the
cerebellum when labeled with either mAb P4 or 6H4. The origin
of this additional band is not clear, but it may be specific to either
the host E211K genotype or to E211K BSE-H inoculum. The
23 kDa band is not present after deglycosylation leaving a single
band that appears similar to other BSE-H isolates (Fig. 5D).
Passage of E211K BSE-H in normal cattle and passage of non-
E211K BSE-H in E211K cattle will both be required to fully
address this matter. These findings support the idea that BSE-H
represents a spectrum of BSE-isolates that can be categorized by
western blot similarities, but are not a single disease.
The disease reported here was true to the molecular charac-
terization of the case diagnosed in 2006, which is the best
approximation of H-type BSE that may occur later in life in cattle
with the E211K polymorphism. Based on the case history of the
original 2006 E211K BSE case and the fact that the vast majority
of naturally-occurring atypical BSE cases involve older cattle
(.10 yrs of age), we speculate that a pre-clinical period of at least
10 years will be required for BSE-H to naturally occur in E211K
cattle without prior exposure to infectious material. While an
inoculation study cannot definitely prove that the U.S. 2006 BSE-
H case was due to the E211K polymorphism, i.e. an inherited
TSE, the results of this study do suggest that cattle with the K211
allele are predisposed to rapid onset of BSE-H when exposed.
Most significantly it must be determined if the molecular
phenotype of this cattle TSE remains stable when transmitted to
cattle without the E211K polymorphism as several other isolates of
atypical BSE have been shown to adopt a molecular profile
consistent with classical BSE after passage in transgenic mice
expressing bovine PrP
C [40] or multiple passages in wild type mice
[23]. Results of ongoing studies, namely passage of the E211K H-
type isolate into wild-type cattle, will lend further insight into what
role, if any, genetic and sporadic forms of BSE may have played in
the origins of classical BSE. Atypical cases presumably of
spontaneous or, in the case of E211K BSE-H, genetic origins
highlight that it may not be possible to eradicate BSE entirely and
that it would be hazardous to remove disease control measures
such as prohibiting the feeding of meat and bone meal to
ruminants.
Figure 4. Patterns of immunoreactivity (red) in the brain vary
depending on region. Staining patterns observed included (A)
intraglial, stellate in the cerebrum, (B) coalescing throughout the
neuropil of the hippocampus, and (C, D) intraneuronal in the perikarya
of hypoglossal nucleus. Original magnification 406,4 0 6,2 6, and 206,
respectively.
doi:10.1371/journal.pone.0038678.g004
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Animals and Procedures
This experiment was carried out in accordance with the Guide
for the Care and Use of Laboratory Animals (Institute of
Laboratory Animal Resources, National Academy of Sciences,
Washington, DC) and the Guide for the Care and Use of
Agricultural Animals in Research and Teaching (Federation of
Animal Science Societies, Champaign, IL). The protocol was
approved by the Institutional Animal Care and Use Committee at
the National Animal Disease Center (protocol number: 3985). A
calf with the E211K polymorphism confirmed by prnp sequencing
was generated by embryo transfer from the only known female
offspring of the US 2006 atypical BSE case [27]. At approximately
2-months-old, it was inoculated intracranially as described pre-
viously [41] with 1 ml of 10% (w/v) brain homogenate derived
from the 2006 U.S. H-type BSE case associated with the E211K
prion protein polymorphism. Briefly, the calf was sedated with
xylazine, the frontal area was clipped and scrubbed, a 1 cm
midline incision was made in the skin slightly caudal to the
junction of the parietal and frontal bones, and a 1 mm hole was
drilled through the calvarium. A 22 gauge spinal needle was
advanced through the hole perpendicular to the frontal bones until
the tip of the needle made contact with the opposite (bottom) side
of the calvarium. The inoculum was slowly injected as the needle
was withdrawn through the brain. The skin was closed with tissue
glue (Vetbond, 3M, St. Paul, MN, USA).
The calf was observed daily for clinical signs of disease. It was
euthanized and necropsied when unequivocal signs of TSE were
noted (see results). Two sets of tissue samples including represen-
tative sections of liver, kidney, spleen, skin, striated muscles (heart,
tongue, diaphragm, masseter), thoracic aorta, thyroid gland,
turbinates, trachea, lung, tonsils, esophagus, rumen, reticulum,
omasum, abomasum, intestines (ileum), adrenal gland, urinary
bladder, lymph nodes (retropharyngeal, prescapular, mesenteric,
popliteal), tonsils (palatine and nasopharyngeal), nerves (sciatic,
optic, trigeminal), pituitary gland, trigeminal ganglion, brain
(cerebral cortex, cerebellum, midbrain including superior collicu-
lus, brainstem including obex), spinal cord (cervical, thoracic,
lumbar), and eye were collected. The first set was collected into
10% buffered formalin (globes were fixed in Bouin’s fixative),
embedded in paraffin wax, and sectioned at 5 mm for staining with
hematoxylin and eosin (HE) and anti-prion protein antibodies.
The second set of tissues was frozen.
Electroretinography
Electroretinography was performed prior to inoculation and at
6 and 9 months post-inoculation as previously described [33] with
slight modification of the testing protocol. An EPIC 4000 visual
electrodiagnostic testing system (LKC Technologies, Gaithers-
burg, MD) with a CMGS-1 Color Mini-Ganzfeld Stimulator
(LKC Technologies, Gaithersburg, MD) was used to capture
electroretinograms (ERG). The left eye was tested at each time
point. The calf was dark adapted for 20 minutes, followed by
a series of 3 scotopic recordings (single white flash 0.024 cdNs/m
2,
single white flash 2.45 cdNs/m
2, oscillatory potentials), 10 minutes
of light adaptation, and 2 photopic recordings (single white flash
2.45 cdNs/m
2 and 59 Hz flicker). B-wave amplitude and implicit
time were measured for each single-flash ERG.
Optical Coherence Tomography
Retinal thickness was measured in vivo using optical coherence
tomography (OCT). A Bioptigen SD-OCT (Bioptigen, Durham,
NC USA) was used to capture linear B scans (10 mm; 1000 A
scans/B scan). At each time point at least 10 measurements of
retinal thickness were taken from multiple scan frames (using on-
screen calipers) to determine an average thickness measurement.
The values reported are +/2 standard deviation of the
measurements.
Histopathology and Immunohistochemistry
Vacuolation profiles were generated by examining defined
regions of brain on hematoxylin and eosin stained sections and
scoring the level of vacuolation. Gray matter regions evaluated
included the piriform cortex, rostral cerebral cortex, caudate
nucleus, thalamic nuclei, rostral (superior) colliculus, hippocam-
pus, caudal (inferior) colliculus, central/periaqueductal gray
matter, reticular formation at the level of the pons, pontine
nuclei, nodulus and flocculus of the cerebellum, and the para-
sympathetic nucleus of the vagus nerve, hypoglossal motor
nucleus, and reticular formation at the level of the obex. White
matter was evaluated in the rostral cerebrum and cerebellum. For
gray matter, scores were assigned as follows: 0=no vacuolation;
1=occasional vacuole indicative of aging or spongiform enceph-
alopathy (SE), but diagnosis inconclusive; 2=definitive SE defined
as the presence of crisp, round to oval vacuoles within neurons
and/or neuropil, but no even spread of vacuoles; 3=even spread
of vacuoles throughout the region with coalescence of some
vacuoles; 4=heavy, even spread of vacuoles throughout the region
with frequent coalescence (most severe). For white matter: 0=no
Figure 5. Western blot analysis with a panel of monoclonal antibodies. (A) Samples from five brain regions of calf #83 demonstrate the
characteristic 3-band profile of PrP
Sc when developed with mAb 6H4. The unglycosylated, monoglycosylated, and diglycosylated bands are of similar
intensity. Note the presence of an additional band at approximately 23 kDa in the sample from cerebellum. (B) Western blot analysis with
monoclonal antibody P4 showing the characteristic 3 band profile of PrP
Sc for both E211K and BSE-H, but an absence of detectable PrP
Sc for classical
BSE. (C) Western blot analysis with mAb SAF-84 showing comparison of PrP
Sc profiles in brain of classical, E211K, and H-type BSE. E211K and H-type
BSE have a 4
th band at 14 kDa, whereas classical BSE does not. (D) All BSE-H samples appear similar after PNGase F treatment (mAb 6H4). Samples
were loaded at 0.6–0.8 mg (A–C) or 0.1–0.3 mg (D) equivalents of brain tissue per lane. Molecular weight standards flank the blot and the molecular
weight in kDa is indicated to the left of the blot.
doi:10.1371/journal.pone.0038678.g005
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1=definite SE, but no even spread; 2=even spread of SE
throughout the region; 3=heavy, even spread of SE throughout
the region with frequent coalescence (most severe).
All paraffin-embedded tissues were also stained by an automat-
ed immunohistochemical method for detection of PrP
Sc as
described previously [42] with slight modifications. Briefly, after
deparaffinization and rehydration, tissue sections were autoclaved
for 30 minutes in an antigen retrieval solution (DAKO Target
Retrieval Solution, DAKO Corp., Carpinteria, CA) and stained
with an indirect, biotin-free staining system containing an alkaline
phosphatase labeled secondary antibody (ultraview Universal
Alkaline Phosphatase Red Detection Kit, Ventana Medical
Systems, Inc., Tucson, AZ) designed for an automated immunos-
tainer (NexES IHC module, Ventana Medical Systems, Inc.,
Tucson, AZ). The primary antibody used was F99/97.6.1 [43] at
a concentration of 5 mg/ml, and incubation was carried out at
37uC for 32 minutes. Images for the figures were captured using
a Nikon DS camera on a Nikon Eclipse 80i microscope. Sections
of the brain at the levels of frontal cortex, parietal cortex, occipital
cortex, rostral colliculus, obex and spinal cord were examined for
patterns of immunoreactivity as previously described for scrapie
[44].
Western Blot
Samples were prepared as a 10% (w/v) (1 mg/10 ml) brain
homogenate in 16homogenization buffer (Prionics AG, Switzer-
land). The samples were digested with proteinase K using a final
enzyme concentration of 4 U/ml (80 mg/ml) at 37uC for 1 hour.
The digestion was stopped by addition of Pefabloc to a final
concentration of 0.1 mg/ml. Samples were diluted 1:4 in 46SDS-
PAGE sample and analyzed by standard western blotting
procedures. The tissue equivalent for loading was empirically
derived with the goal of providing a reasonable signal for each
case, and in all cases shown here, was loaded with between 0.6 and
0.8 mg equivalents of brain per lane. Western blot detection was
conducted using mouse anti-PrP monoclonal antibodies P4 or 6H4
at a 1:10,000 dilution (0.1 mg/ml), F99/97.6.1 at a 1:1000 dilution
(1 mg/ml), or SAF 84 at 1:200 dilution (1 mg/ml) as the primary
antibody. A biotinylated sheep anti-mouse secondary antibody at
0.05 mg/ml and a streptavidin-HRP conjugate, were used in
conjunction with the ECL Plus detection system and visualized on
a Kodak Invivo-F imaging system. Primary antibody incubations
were conducted with the membrane at either room temperature
for 1 hour or 4uC overnight ($12 hours). Secondary antibody and
streptavidin-HRP conjugate incubations were conducted at room
temperature for 1 hour.
Deglycosylation of PrP-res was accomplished using PNGase F
(New England Biolabs) with slight modifications from the
manufacturer’s instructions. Briefly, 5–10 ml of 10% brain
homogenate was PK digested as above and denatured in sodium
dodecyl sulfate (final concentration 3% w/v) at 100uC for
10 minutes, instead of using the denaturing buffer supplied. The
PK-digested, denatured homogenates (5–10 ml) were incubated
with PNGase F (final concentration 150 U/ml) at 37uC for
$16 hours. The samples were combined with loading buffer and
heated to 100uC for 5 minutes prior to gel electrophoresis.
Supporting Information
Figure S1 Vacuolation scores in gray matter regions of
the brain. The vast majority of brain regions had definitive
spongiform lesions (score .1). Brain regions: 1, piriform cortex; 2,
rostral cerebral cortex; 3, caudate nucleus; 4, thalamic nuclei; 5,
rostral colliculus; 6, hippocampus; 7, caudal colliculus; 8, central/
periaqueductal gray matter; 9, pons – reticular formation; 10,
pontine nuclei; 11, cerebellum – nodulus; 12, cerebellum –
flocculus; 13, obex – parasympathetic nucleus of the vagus nerve;
14, obex – hypoglossal motor nucleus; 15, obex – reticular
formation.
(TIF)
Figure S2 Patterns of PrP
Sc immunoreactivity in neuro-
hypophysis, trigeminal ganglion, and spinal cord. (A)
Immunoreactivity is present throughout the neurohypophysis, but
not in the adenohypophysis (pars intermedia in upper portion of
image). Original magnification 206.( B) Weak intraneuronal
immunoreactivity is present in a minority of sensory neuron
perikarya in the trigeminal ganglion. Original magnification 406,
(C) Immunoreactivity is present throughout the gray matter of the
spinal cord. Original magnification is 26.( D) In the ventral horn
of the spinal cord, immunoreactivity is throughout the neuropil
and in lesser amounts within motor neuron perikarya. Original
magnification 206.
(TIF)
Figure S3 Patterns of PrP
Sc immunoreactivity in white
matter and cerebellum. (A) Sparse immunoreactivity in the
white matter subjacent to the cerebral cortex is primarily cell
associated. Original magnification 406.( B) PrP
Sc immunoreac-
tivity is present in low amounts in cerebellar molecular and
granular layers. Original magnification 206.( C) PrP
Sc immuno-
reactivity is rare in the cerebellar white matter with exception of
areas adjacent the deep cerebellar nuclei. Original magnifcation
406.
(TIF)
Table S1 Numerical results of electroretinograms. B-
wave amplitude increased for all tests from 0 to 6 MPI, but did not
appreciably change from 6 to 9 MPI. The average b-wave implicit
time increased substantially over the course of disease. Test 1, dark
adapted 0.024 cd?s/m
2; test 2, dark adapted 2.45 cd?s/m
2; test 3,
light adapted 2.45 cd?s/m
2. Abbreviations: A=amplitutde;
IT=implicit time; cd?s/m
2=candela seconds per meter squared;
msec=milliseconds.
(DOCX)
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